Yuken India Limited reported mixed FY26 results with consolidated revenue growing marginally by 1.1% to ₹466.18 crore but net profit declining sharply by 41% to ₹14.39 crore. The profit decline was primarily driven by increased operational costs and expenses rising 3.18% to ₹443.75 crore. Standalone performance showed modest improvement with PBT up 1.23% to ₹18.19 crore.
Financial Highlights:
- Consolidated EPS dropped to ₹10.81 from ₹18.94 previous year
- Total assets stood at ₹635.23 crore with cash equivalents of ₹22.41 crore
- Borrowings increased to ₹103.37 crore from ₹88.62 crore
- Trade receivables remained elevated at ₹118.82 crore
Corporate Actions: The Board recommended a final dividend of ₹1.50 per share (15%) with estimated outflow of ₹2.04 crore. The company raised ₹59.92 crore through preferential allotment of 584,000 shares to promoter Yuken Kogyo at ₹1,026 per share, increasing promoter holding to 58.04%.
Management Changes: Significant leadership transitions occurred with CEO A. Venkata Krishnan resigning and Rakesh Kumar A appointed as new CEO effective April 29, 2026. Multiple board changes were implemented throughout FY26 with new appointments and resignations.
Subsidiary Performance: Subsidiaries showed mixed results - Grotek Enterprises PAT declined 24.6% to ₹5.59 crore, while Coretec Engineering and Kolben Hydraulics reported increased losses of ₹1.95 crore and ₹1.77 crore respectively. The company provided corporate guarantees totaling ₹73.40 crore to subsidiaries.
Risk Exposure: The company reported heightened foreign currency risk with sensitivity to 1% USD change impacting ₹7.65 lakhs, and interest rate risk with variable rate borrowings of ₹97.58 crore exposing to 100 bps change impacting ₹97.58 lakhs. Credit risk exposure reached ₹145.93 crore.
Governance & Compliance: Auditors provided unmodified opinions with key audit matters on revenue recognition and subsidiary impairment assessments. Minor non-compliances included advertisement and filing delays with ₹140,000 penalty paid. CSR expenditure of ₹3.27 million met obligations focusing on education and healthcare.
The company maintained CARE BBB+ (Stable) credit rating and reported strong liquidity with net cash from operations of ₹29.66 crore, though investing activities used ₹72.06 crore mainly for capital expenditure.